Molecular Research Inc., Sun Pharmaceuticals, AstraZeneca, Merck & Co, Inc., BASF SE, and
Teva Pharmaceuticals. In March 2012, the FDA approved Ilumya (Tildrakizumab-asmn)
developed by Sun Pharmaceuticals used for Plaque Psoriasis.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/small-molecule-api-market-2423
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com